DTL
VRCA icon

Dynamic Technology Lab’s Verrica Pharmaceuticals VRCA Stock Holding History

Dynamic Technology Lab’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,030
Closed -$11K – 1250
2025
Q2 		$11K Buy
+2,030
New +$10.9K ﹤0.01% 886

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Dynamic Technology Lab's VRCA Position: Q3 2025 in Review

Dynamic Technology Lab sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 2,030 shares — an estimated $11K sold.

Dynamic Technology Lab first reported a position in VRCA in Q2 2025 and held it in 1 quarter. The position peaked at $11K in Q2 2025. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

  • Dynamic Technology Lab reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 2,030 Verrica Pharmaceuticals shares in Q3 2025, an estimated $11K.
  • Dynamic Technology Lab first reported a position in Verrica Pharmaceuticals in Q2 2025 and held it in 1 quarter.
  • Dynamic Technology Lab's Verrica Pharmaceuticals position peaked at $11K in Q2 2025.
  • 34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.